A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses - 07/09/11
Abstract |
Background: Photodynamic therapy (PDT) has not been compared with topical 5-fluorouracil (5-FU) in the treatment of epidermal dysplasia. Objective: The purpose of this study was to assess the efficacy and tolerability of these two treatment modalities in 17 patients with actinic keratoses on the backs of the hands. Methods: Each patient’s right and left hands were randomized to receive either a 3-week course of topical 5-FU applied twice per day or PDT using topical 5-aminolevulinic acid (5-ALA) and then, after 4 hours, irradiation with an incoherent light source consisting of a 1200 W metal halogen lamp emitting red light (580 to 740 nm). Each hand randomized for PDT received 150 J/cm2. The observed median fluence rate was 86 mW/cm2 (interquartile range, 53 to 100 mW/cm2). All patients were reviewed at 1, 4, and 24 weeks after starting treatment. Results: Fourteen of 17 patients (82%) completed the study. The mean lesional area treated with topical 5-FU decreased from 1390 mm2 (standard deviation [SD], 1130) to 297 mm2 (SD, 209). This represents a mean reduction in lesional area of 70% (confidence interval [CI], 61%-80%). The mean lesional area treated with topical PDT decreased from 1322 mm2 (SD, 1280) to 291 mm2 (SD, 274), representing a mean reduction in lesional area of 73% (CI, 61%-84%). The reduction in lesional area elicited by the two treatment methods was similar (CI, –25% to 17%). There was no statistically significant difference between the treatment methods in overall symptom scores for pain and redness. Conclusion: One treatment with PDT using topical 5-ALA appears to be as effective and well tolerated as 3 weeks of twice-daily topical 5-FU, a cheap and widely available alternative. (J Am Acad Dermatol 1999;41:414-8.)
Le texte complet de cet article est disponible en PDF.Plan
From the Dermatological Surgery & Laser Unit, St John’s Institute of Dermatology, St Thomas’ Hospital,a and the Department of Public Health Medicine, GKT School of Medicine, Kings College.b |
|
Reprint requests: Richard J. Barlow, MD, Dermatological Surgery & Laser Unit, St John’s Institute of Dermatology, St Thomas’ Hospital, London SE1 7EH, United Kingdom. |
|
0190-9622/99/$8.00 + 0 16/1/99378 |
Vol 41 - N° 3
P. 414-418 - septembre 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?